Business ยท National
USFDA issues 7 observations to NATCO Pharma's Hyderabad facility
NATCO Pharma says the observations are believed to be procedural in nature and is confident of addressing them in time
Verified Timeline
No verified timeline updates.
What is your view on โUSFDA issues 7 observations to NATCO Pharma's Hyderabad facilityโ?
This is self-selected reader participation, not representative scientific polling.

